Cargando…
Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies
Pegylated liposomal doxorubicin (PLD) is a palliative treatment option for patients with recurrent gynecologic malignancies. It has an appealing toxicity profile and responses can be prolonged. There is no consensus as to the level of cardiac toxicity. Current label warnings, National Comprehensive...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710555/ https://www.ncbi.nlm.nih.gov/pubmed/31467958 http://dx.doi.org/10.1016/j.gore.2019.07.012 |